Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy

被引:185
作者
Kemi, Ole Johan [1 ,2 ]
Ceci, Marcello [3 ,4 ]
Wisloff, Ulrik [2 ,5 ]
Grimaldi, Serena [3 ,4 ]
Gallo, Paolo [3 ,4 ]
Smith, Godfrey L. [1 ]
Condorelli, Gianluigi [3 ,4 ,6 ]
Ellingsen, Oyvind [2 ,5 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway
[3] Ist Ricovero & Cura Carattere Sci Multimed, Milan, Italy
[4] Fdn Parco Sci San Raffaele, Rome, Italy
[5] St Olavs Hosp, Dept Cardiol, Trondheim, Norway
[6] Univ Calif San Diego, Div Cardiol, Dept Med, La Jolla, CA 92093 USA
关键词
D O I
10.1002/jcp.21197
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiomyocyte hypertrophy differs according to the stress exerted on the myocardium. While pressure overload-induced cardiomyocyte hypertrophy is associated with depressed contractile function, physiological hypertrophy after exercise training associates with preserved or increased inotropy. We determined the activation state of myocardial Akt signaling with downstream substrates and fetal gene reactivation in exercise-induced physiological and pressure overload-induced pathological hypertrophies. C57BL/6J mice were either treadmill trained for 6 weeks, 5 days/week, at 85-90% of maximal oxygen uptake (VO2max), or underwent transverse aortic constriction (TAC) for 1 or 8 weeks. Total and phosphorylated protein levels were determined with SDS-PAGE, and fetal genes by real-time RT-PCR. In the physiologically hypertrophied heart after exercise training, total Akt protein level was unchanged, but Akt was chronically hyperphosphorylated at serine 473. This was accompanied by activation of the mammalian target of rapamycin (mTOR), measured as phosphorylation of its two substrates: the ribosomal protein S6 kinase-I (S6KI) and the eukaryotic translation initiation factor-4E binding protein-I (4E-BPI). Exercise training did not reactivate the fetal gene program (beta-myosin heavy chain, atrial natriuretic factor, skeletal muscle actin). In contrast, pressure overload after TAC reactivated fetal genes already after I week, and partially inactivated the Akt/mTOR pathway and downstream substrates after 8 weeks. In conclusion, changes in opposite directions of the myocardial Akt/mTOR signal pathway appears to distinguish between physiological and pathological hypertrophies; exercise training associating with activation and pressure overload associating with inactivation of the Akt/mTOR pathway.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 50 条
[31]   A session of strength exercise induced cardiac hypertrophy by AT1 receptor-AKT-mTOR signaling pathway [J].
Soares Melo, Stephano Freitas ;
Amadeu, Marco Aurelio ;
Fernandes, Tiago ;
Carmo, Everton Crivoi ;
Magalhaes, Flavio Castro ;
Mendes Barreti, Diego Lopes ;
Reno Socci, Ursula Paula ;
Alves, Cleber Rener ;
Roque Redondo, Fernanda Roberta ;
Brum, Patrcia Chakur ;
Oliveira, Edilamar Menezes .
FASEB JOURNAL, 2010, 24
[32]   Flavonoids Extraction from Propolis Attenuates Pathological Cardiac Hypertrophy through PI3K/AKT Signaling Pathway [J].
Sun, Guang-wei ;
Qiu, Zhi-dong ;
Wang, Wei-nan ;
Sui, Xin ;
Sui, Dian-jun .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
[33]   Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia [J].
Tong, Wing-Hang ;
Ollivierre, Hayden ;
Noguchi, Audrey ;
Ghosh, Manik C. ;
Springer, Danielle A. ;
Rouault, Tracey A. .
HELIYON, 2022, 8 (08)
[34]   TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling [J].
Zhao, Ting ;
Wang, Zhenyu ;
Chi, Yehong ;
Ni, Chunmei ;
Zheng, Xudan .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (05)
[35]   Protein Kinase A Is a Master Regulator of Physiological and Pathological Cardiac Hypertrophy [J].
Bai, Yingyu ;
Zhang, Xiaoying ;
Li, Ying ;
Qi, Fei ;
Liu, Chong ;
Ai, Xiaojie ;
Tang, Mingxin ;
Szeto, Christopher ;
Gao, Erhe ;
Hua, Xiang ;
Xie, Mingxing ;
Wang, Xuejun ;
Tian, Ying ;
Chen, Yongjie ;
Huang, Guowei ;
Zhang, Junping ;
Xiao, Weidong ;
Zhang, Lili ;
Liu, Xueyuan ;
Yang, Qing ;
Houser, Steven R. ;
Chen, Xiongwen .
CIRCULATION RESEARCH, 2024, 134 (04) :393-410
[36]   Unique Cardiac Fibroblast Expression Profiles in Pathological and Physiological Hypertrophy [J].
Lighthouse, Janet K. ;
Velasquez, Lissette S. ;
Small, Eric M. .
CIRCULATION RESEARCH, 2014, 115
[37]   Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy [J].
Abel, E. Dale ;
Doenst, Torsten .
CARDIOVASCULAR RESEARCH, 2011, 90 (02) :234-242
[38]   Modulation of Impact of Obesity in Pathological and Physiological Cardiac Hypertrophy by Orlistat [J].
Singh, Randhir ;
Singh, Manjeet ;
Krishan, Pawan .
LATIN AMERICAN JOURNAL OF PHARMACY, 2010, 29 (05) :754-762
[39]   Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy [J].
Wilkins, BJ ;
Dai, YS ;
Bueno, OF ;
Parsons, SA ;
Xu, J ;
Plank, DM ;
Jones, F ;
Kimball, TR ;
Molkentin, JD .
CIRCULATION RESEARCH, 2004, 94 (01) :110-118
[40]   OVARIECTOMY PREVENTS PHYSIOLOGICAL AND POTENTIATES PATHOLOGICAL CARDIAC-HYPERTROPHY [J].
MALHOTRA, A ;
BUTTRICK, PM ;
SCHEUER, J .
CIRCULATION, 1987, 76 (04) :235-235